Lpl Financial LLC Mesoblast LTD Transaction History

Lpl Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.39 $2 - $2	2 Added 0.02%	12,877 $14,000
Q2 2023 Jul 31, 2023	BUY	$2.95 - $4.44 $5,900 - $8,880	2,000 Added 18.39%	12,875 $50,000
Q1 2023 May 10, 2023	SELL	$2.94 - $4.18 $294 - $418	-100 Reduced 0.91%	10,875 $35,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $3.48 $156 - $1,137	-327 Reduced 2.89%	10,975 $28,000
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $11,740 - $15,700	-2,000 Reduced 15.04%	11,302 $68,000
Q2 2021 Aug 13, 2021	SELL	$6.69 - $9.0 $9,620 - $12,942	-1,438 Reduced 9.76%	13,302 $99,000
Q1 2021 May 14, 2021	BUY	$8.26 - $11.4 $121,752 - $168,036	14,740 New	14,740 $122,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.